Inhaled Drug Delivery Summit 2014
November 5 - 6, 2014
london , United Kingdom
The conference programme will include:
Is it the end of the road for MDIs?
Can we improve the way we perform clinical trials.
ASAP.
Parallel Multiple drug/device development.
Globalising the Breezehaler.
Novel Inhalation Therapy.
Bioequivalence guidance.
EMA OIP Guidance.
Emerging Markets: Inhalation products for asthma COPD in China.
Formulation: Inhalation strategies to treat respiratory infections.
Technology: Investigating the output of different inhalers and Nicotine inhalers.
Conference Date: 05-06 Nov 2014
Conference Ref: N11-8114
Fee: £1350 + VAT
Venue: The Rembrandt Hotel, London
Co-chairmen: Dr.Steve Nichols and Dr Ian Smith
KEYNOTE ADDRESS:
Professor Peter Barnes, Professor of Thoracic Medicine and Head of Respiratory Medicine, National Heart and Lung Institute
Is it the end of the road for MDIs?
Can we improve the way we perform clinical trials.
ASAP.
Parallel Multiple drug/device development.
Globalising the Breezehaler.
Novel Inhalation Therapy.
Bioequivalence guidance.
EMA OIP Guidance.
Emerging Markets: Inhalation products for asthma COPD in China.
Formulation: Inhalation strategies to treat respiratory infections.
Technology: Investigating the output of different inhalers and Nicotine inhalers.
Conference Date: 05-06 Nov 2014
Conference Ref: N11-8114
Fee: £1350 + VAT
Venue: The Rembrandt Hotel, London
Co-chairmen: Dr.Steve Nichols and Dr Ian Smith
KEYNOTE ADDRESS:
Professor Peter Barnes, Professor of Thoracic Medicine and Head of Respiratory Medicine, National Heart and Lung Institute
Organizer
+44 (0) 1483 730071Related events
Inhaled Drug Delivery Summit November 5 - 6, 2014
